The following sections of the Standards of Medical Care in Diabetes—2021 have been updated to include the latest evidence-based recommendations from the American Diabetes Association: Classification and Diagnosis of Diabetes, Cardiovascular Disease and Risk Management, and Microvascular Complications and Foot Care. To access the updates, please visit

Women are broadly underrepresented in scientific leadership positions. Despite increasing recognition of gender imbalance in research and medicine, many disparities in the field of diabetes persist. The article “The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence” analyzes multiple aspects of historical and present-day female representation in the diabetes field. The full study and accompanying commentaries can be accessed online at

The International Diabetes Federation (IDF) Congress 2021 will be held virtually on 6–11 December 2021. The IDF Virtual Congress will provide an update on the latest research and tools to manage and prevent diabetes complications and include a dedicated stream on COVID-19 and diabetes. Registration and abstract submission are open. Please visit for further information.

This self-paced, online program delivers easily accessible continuing education to meet the needs of busy primary care providers. This bundle, offering up to 10 continuing education credits or American Board of Internal Medicine Maintenance of Certification points, offers nine modules as well as exclusive, “Ask the Expert” live events, an online learning collaborative to share best practices and network with colleagues, and a 1-year American Diabetes Association professional membership. For more information, please visit

Diabetic kidney disease remains an important clinical problem with substantial medical comorbidity despite many recent medical advances. As more therapeutic opportunities become established, an improved understanding of the mechanisms underlying the progression of diabetic vascular disease and target organ damage is needed so that newer and traditional therapeutic options can be used together most efficiently to improve clinical outcomes. This compendium, supported by unrestricted education grants from AstraZeneca and Bayer, provides an opportunity to gauge progress in the efforts underway to improve longer-term outcomes for patients who have diabetes and chronic kidney disease. Access the PDF for free at

“Diabetes and COVID-19” is an online collection of articles on the Diabetes Care website featuring the latest studies, clinical observations, and commentaries on COVID-19 with specific relation to patients with diabetes. Topics include management of diabetes and its complications during the pandemic, blood glucose control and remote glucose monitoring, and outcomes in patients with hyperglycemia, cardiovascular risk, and obesity. This web page is updated regularly as relevant Diabetes Care articles are published online ahead of print. To access the collection, visit

Diabetes Core Update is a monthly audio podcast devoted to presenting and discussing the latest clinically relevant articles from the American Diabetes Association’s scholarly journals. Diabetes Core Update audio podcasts are free and can be accessed through iTunes or RSS feed. For more information, please visit

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at